These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24727988)

  • 1. Successes and limitations of targeted cancer therapy in melanoma.
    Romano E; Michielin O
    Prog Tumor Res; 2014; 41():78-88. PubMed ID: 24727988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations and personalized medicine in melanoma: progress and future prospects.
    Griewank KG; Scolyer RA; Thompson JF; Flaherty KT; Schadendorf D; Murali R
    J Natl Cancer Inst; 2014 Feb; 106(2):djt435. PubMed ID: 24511108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in targeted therapy for unresectable melanoma: new drugs and combinations.
    Hao M; Song F; Du X; Wang G; Yang Y; Chen K; Yang J
    Cancer Lett; 2015 Apr; 359(1):1-8. PubMed ID: 25578781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting metastatic melanoma.
    Flaherty KT
    Annu Rev Med; 2012; 63():171-83. PubMed ID: 22034865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy for melanoma: rational combinatorial approaches.
    Kwong LN; Davies MA
    Oncogene; 2014 Jan; 33(1):1-9. PubMed ID: 23416974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up close and personal: the challenges of precision medicine in melanoma.
    Smalley KS; Weber JS
    J Natl Cancer Inst; 2014 Feb; 106(2):djt443. PubMed ID: 24511111
    [No Abstract]   [Full Text] [Related]  

  • 7. Precision Medicine in the Treatment of Melanoma.
    Aderhold K; Wilson M; Berger AC; Levi S; Bennett J
    Surg Oncol Clin N Am; 2020 Jan; 29(1):1-13. PubMed ID: 31757306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma stem cells.
    Roesch A
    J Dtsch Dermatol Ges; 2015 Feb; 13(2):118-24. PubMed ID: 25631128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic treatment of inoperable metastasized malignant melanoma].
    Gutzmer R; Rauschenberg R; Meier F
    Hautarzt; 2016 Jul; 67(7):529-35. PubMed ID: 27164828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Future targeting of the RAS/RAF/MEK/ERK signaling pathway in oncology: the example of melanoma].
    Favre G
    Bull Acad Natl Med; 2014 Feb; 198(2):321-36; discussion 337-8. PubMed ID: 26263707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successes and limitations of targeted cancer therapy in breast cancer.
    Curigliano G; Criscitiello C
    Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drug targets in metastatic melanoma.
    Homet B; Ribas A
    J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma genetics: the other side.
    Bis S; Tsao H
    Clin Dermatol; 2013; 31(2):148-55. PubMed ID: 23438378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Society of Clinical Oncology Developing First Clinical Trial.
    Brower V
    J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating metastatic melanoma in 2014: what just happened and what is next?
    Chapman PB
    Am Soc Clin Oncol Educ Book; 2014; ():16-9. PubMed ID: 24857055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutic options in the medical management of advanced melanoma.
    Lutzky J
    Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major therapeutic developments and current challenges in advanced melanoma.
    Sullivan RJ; Flaherty KT
    Br J Dermatol; 2014 Jan; 170(1):36-44. PubMed ID: 24443912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapeutical strategies in the treatment of metastatic disease.
    Julia F; Thomas L; Dalle S
    Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current state of targeted therapy in melanoma: this time it's personal.
    Smalley KS; McArthur GA
    Semin Oncol; 2012 Apr; 39(2):204-14. PubMed ID: 22484192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular alterations in melanoma and targeted therapies].
    Mourah S; Lebbé C
    Bull Cancer; 2014 Dec; 101 Suppl 2():S5-S11. PubMed ID: 25776766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.